Tara Haelle, Everyday Health

Tara Haelle

Everyday Health

DFW Airport, TX, United States

Contact Tara

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Unknown
  • Everyday Health
  • The New York Times
  • STAT
  • Pia Christensen
  • Forbes
  • Medium
  • WHYY
  • NPR
  • Moneyish
  • 90.7 WMFE
  • and more…

Past articles by Tara:

What Is Breast Cancer? Symptoms, Causes, Diagnosis, Treatment, and Prevention

Breast cancer symptoms, signs of breast cancer, triple negative breast cancer, breast cancer stages, causes and types of breast cancer, and more. This need-to-know guide prepares you for the journey. → Read More

This Is the Moment the Anti-Vaccine Movement Has Been Waiting for

Anti-vaccine activists are more politically savvy and dangerous than ever before. → Read More

Postpartum Depression Can Be Dangerous. Here’s How to Recognize It and Seek Treatment.

The sooner this serious mental health issue is diagnosed, the sooner it can be treated. Knowing your risk factors is the first step. → Read More

Opinion | What Can You Do Once You’re Vaccinated?

You have to do your own risk assessment. Here's how. → Read More

Global trends in lung cancer show continuing disparities

With over 2 million new cases globally in 2018, lung cancer remains the most prevalent cancer in the world. → Read More

Pfizer vaccine news sounds great — but it’s still data by press release

Pfizer made waves Monday with its announcement that its COVID-19 vaccine, developed with partner BioNTech, is “strongly effective,” with a reported efficacy of over 90%. The news was so highly tout… → Read More

Get prepared now to cover the COVID-19 vaccine

The race for a COVID-19 is heating up. At least two COVID-19 vaccine makers ― Pfizer and Moderna ― may have enough clinical trial data to begin seeking U.S. regulatory approval in December, accordi… → Read More

While still an expensive therapy, doctors see promise in harnessing a patient’s immune system to fight cancer

If you write anything about cancer treatment, it’s nearly impossible to avoid writing about immunotherapy. But reporting on immunotherapy can quickly become complex, confusing and overwhelming. A n… → Read More

New resource can help you assess hazards and risks and odds ratios

Over the years, I’ve presented on reporting medical research findings. Some of the most common questions I get are about writing the findings using accessible language that an average person can un… → Read More

Use analogies to provide perspective for tricky numbers ― such as COVID-19 fatality rates

It’s no secret that humans are horrible at comprehending and estimating risk, especially when it comes to abstract numbers. It’s one reason (of several) that people fear encountering sharks at the … → Read More

Know the nuances of vaccine efficacy when covering COVID-19 vaccine trials

I’ve written In previous posts about what to look for in COVID-19 vaccine trials and red flags to monitor. The two most important outcomes in vaccine trials are the vaccine’s safety and its efficac… → Read More

Freshen your skills with online course on reading medical studies

When it comes to feeling competent about understanding, interpreting and reporting on medical studies, one under-appreciated fact is that this is a long-term learning process. I first began to real… → Read More

The Most Important Things To Know About Blood Clots

Blood clots are responsible for one in four deaths globally if you include heart attacks and strokes, but people working from home may be at higher risk for pulmonary embolism too. → Read More

Tracker a one-stop-shop for monitoring COVID-19 vaccine development

It’s been a dizzying task for reporters trying to keep up with the development of COVID-19 vaccines. There are the U.S. candidates in various clinical trial stages, candidates within the U.S. that … → Read More

Watch out for these red flags in COVID-19 vaccine trials

In a previous blog post, I discussed what reporters look for when they dig into the data from the various COVID-19 vaccine clinical trials. That post covered the do’s, but it didn’t cover the red f… → Read More

What to look for in COVID-19 vaccine trials

As various COVID-19 vaccine candidates make their way through clinical trials — see this nice update on where things stand from Helen Branswell at STAT — journalists need to be scrutinizing the fin… → Read More

How reporting on people’s intent to get a COVID-19 vaccine can harm public health

A recent Pew Research poll found that the proportion of Americans who said they would get a COVID-19 vaccine when it is released has dropped sharply since May. This isn’t necessarily very surprisin… → Read More

New PubMed officially the default but still a work in progress

If you’re a frequent user of PubMed, you have likely already noticed the new website layout and have probably noticed some differences in search options or functionality. The new PubMed was first t… → Read More

Can people with low literacy easily access accurate info about COVID-19?

Nothing is more important during a pandemic than ensuring that the public consistently receives accurate information that they can understand. But even government websites designed with the intent … → Read More

Bias or comorbidity? Risk factors for respiratory disease aren’t always what they seem

By this point, anyone who’s been covering or following COVID-19 knows that several comorbidities substantially increase the risk of complications and severe disease. Among those mentioned most ofte… → Read More